LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
33.54
-0.37 (-1.09%)
Nov 21, 2024, 11:13 AM EST - Market open
LENZ Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$35.40
Upside
+5.55%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +13.30% | Nov 7, 2024 |
| Raymond James | Raymond James | Buy Initiates $37 | Buy | Initiates | $37 | +10.32% | Sep 27, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $36 | Buy | Maintains | $36 | +7.33% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +13.30% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $38 | Strong Buy | Initiates | $38 | +13.30% | Aug 12, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $32 | Buy | Initiates | $32 | -4.59% | Apr 15, 2024 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 15, 2024 |
| Citigroup | Citigroup | Strong Buy Initiates $34 | Strong Buy | Initiates | $34 | +1.37% | Apr 10, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $28 | Buy | Initiates | $28 | -16.52% | Mar 27, 2024 |